OMNICOM GROUP INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that OMNICOM GROUP INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.27B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $15.69B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $14.69B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $14.29B | Feb 5, 2025 |
| FY2023 | Dec 31, 2021 | $14.29B | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $13.17B | Feb 8, 2023 |
| FY2019 | Dec 31, 2019 | $4.14B | Feb 11, 2020 |
| FY2019 | Sep 30, 2019 | $3.62B | Feb 11, 2020 |
| FY2019 | Jun 30, 2019 | $3.72B | Feb 11, 2020 |
| FY2019 | Mar 31, 2019 | $3.47B | Feb 11, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($54.50M) | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $1.48B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $1.39B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $1.32B | Feb 5, 2025 |
| FY2023 | Dec 31, 2021 | $1.41B | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $945.40M | Feb 8, 2023 |
| FY2019 | Dec 31, 2019 | $415.00M | Feb 11, 2020 |
| FY2019 | Sep 30, 2019 | $290.20M | Feb 11, 2020 |
| FY2019 | Jun 30, 2019 | $370.70M | Feb 11, 2020 |
| FY2019 | Mar 31, 2019 | $263.20M | Feb 11, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $444.70M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $2.27B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $2.10B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $2.08B | Feb 5, 2025 |
| FY2023 | Dec 31, 2021 | $2.20B | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $1.60B | Feb 8, 2023 |
| FY2019 | Dec 31, 2019 | $646.40M | Feb 11, 2020 |
| FY2019 | Sep 30, 2019 | $473.30M | Feb 11, 2020 |
| FY2019 | Jun 30, 2019 | $573.70M | Feb 11, 2020 |
| FY2019 | Mar 31, 2019 | $428.90M | Feb 11, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $745.70M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $408.10M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $393.70M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $378.50M | Feb 5, 2025 |
| FY2023 | Dec 31, 2021 | $379.70M | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $360.50M | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $405.90M | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $455.40M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $439.70M | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $443.90M | Feb 12, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.94B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $1.73B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $1.42B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $926.50M | Feb 5, 2025 |
| FY2023 | Dec 31, 2021 | $1.95B | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $1.72B | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $1.86B | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $1.72B | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $2.02B | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $1.95B | Feb 12, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $149.80M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $140.60M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $78.40M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $78.20M | Feb 5, 2025 |
| FY2023 | Dec 31, 2021 | $665.80M | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $75.40M | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $102.20M | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $195.70M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $156.00M | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $165.50M | Feb 12, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $54.42B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $29.62B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $28.04B | Feb 5, 2025 |
| FY2023 | Dec 31, 2022 | $27.00B | Feb 7, 2024 |
| FY2022 | Dec 31, 2021 | $28.42B | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $27.65B | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | $26.78B | Feb 18, 2021 |
| FY2019 | Jan 1, 2019 | $25.89B | Feb 11, 2020 |
| FY2019 | Dec 31, 2018 | $24.62B | Feb 11, 2020 |
| FY2018 | Dec 31, 2017 | $24.93B | Feb 12, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.05B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $4.19B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $3.62B | Feb 5, 2025 |
| FY2023 | Dec 31, 2022 | $3.25B | Feb 7, 2024 |
| FY2022 | Dec 31, 2021 | $3.27B | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $3.08B | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | $2.85B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $2.55B | Feb 11, 2020 |
| FY2018 | Dec 31, 2017 | $2.62B | Feb 12, 2019 |
| FY2017 | Dec 31, 2016 | $2.16B | Feb 15, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.64B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $10.68B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $10.08B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $9.73B | Feb 5, 2025 |
| FY2023 | Dec 31, 2021 | $9.74B | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $9.61B | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $9.44B | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $9.38B | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $9.34B | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $8.98B | Feb 12, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.78B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $11.50B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $10.57B | Feb 5, 2025 |
| FY2023 | Dec 31, 2022 | $9.74B | Feb 7, 2024 |
| FY2022 | Dec 31, 2021 | $9.00B | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $8.19B | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | $7.81B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $7.02B | Feb 11, 2020 |
| FY2018 | Dec 31, 2017 | $6.21B | Feb 12, 2019 |
| FY2017 | Dec 31, 2016 | $5.68B | Feb 15, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $5.32B | Feb 9, 2022 |
| FY2021 | Dec 31, 2020 | $5.60B | Feb 9, 2022 |
| FY2021 | Dec 31, 2019 | $4.31B | Feb 9, 2022 |
| FY2021 | Dec 31, 2018 | $3.65B | Feb 9, 2022 |
| FY2020 | Dec 31, 2017 | $3.80B | Feb 18, 2021 |
| FY2019 | Dec 31, 2016 | $3.00B | Feb 11, 2020 |
| FY2018 | Dec 31, 2015 | $2.61B | Feb 12, 2019 |
| FY2017 | Dec 31, 2014 | $2.39B | Feb 15, 2018 |
| FY2016 | Dec 31, 2013 | $2.71B | Feb 9, 2017 |
| FY2015 | Dec 31, 2012 | $2.68B | Feb 9, 2016 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.27B | Feb 20, 2026 |
| FY2024 | Dec 31, 2024 | $6.07B | Feb 5, 2025 |
| FY2023 | Dec 31, 2023 | $5.67B | Feb 7, 2024 |
| FY2022 | Dec 31, 2022 | $5.61B | Feb 8, 2023 |
| FY2021 | Dec 31, 2021 | $5.73B | Feb 9, 2022 |
| FY2020 | Dec 31, 2020 | $5.82B | Feb 18, 2021 |
| FY2019 | Dec 31, 2019 | $5.12B | Feb 11, 2020 |
| FY2018 | Dec 31, 2018 | $4.90B | Feb 12, 2019 |
| FY2017 | Dec 31, 2017 | $4.90B | Feb 15, 2018 |
| FY2016 | Dec 31, 2016 | $4.90B | Feb 9, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 7 | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | 6 | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | 6 | Feb 5, 2025 |
| FY2023 | Dec 31, 2021 | 6 | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | 4 | Feb 8, 2023 |
| FY2019 | Dec 31, 2019 | 1 | Feb 11, 2020 |
| FY2019 | Sep 30, 2019 | 1 | Feb 11, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Feb 11, 2020 |
| FY2019 | Mar 31, 2019 | 1 | Feb 11, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 7 | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | 6 | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | 6 | Feb 5, 2025 |
| FY2023 | Dec 31, 2021 | 6 | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | 4 | Feb 8, 2023 |
| FY2019 | Dec 31, 2019 | 1 | Feb 11, 2020 |
| FY2019 | Sep 30, 2019 | 1 | Feb 11, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Feb 11, 2020 |
| FY2019 | Mar 31, 2019 | 1 | Feb 11, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 313.10M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 196.40M | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | 198.00M | Feb 5, 2025 |
| FY2023 | Dec 31, 2022 | 202.70M | Feb 7, 2024 |
| FY2022 | Dec 31, 2021 | 209.10M | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | 215.00M | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | 217.10M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | 223.90M | Feb 11, 2020 |
| FY2018 | Dec 31, 2017 | 230.10M | Feb 12, 2019 |
| FY2017 | Dec 31, 2016 | 234.70M | Feb 15, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $549.60M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $552.70M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $562.70M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $581.10M | Feb 5, 2025 |
| FY2023 | Dec 31, 2021 | $592.30M | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $562.70M | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $564.30M | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $548.50M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $515.20M | Feb 11, 2020 |